Google NewsWhat’s Driving Fresh Interest in Mayne Pharma (ASX:MYX) Shares? - Kalkine
What’s Driving Fresh Interest in Mayne Pharma (ASX:MYX) Shares? Kalkine
MAYNE PHARMA LTD ORDINARY (MYX) News
Latest articles and price-sensitive announcements with AI sentiment classification.
ASXMayne Pharma receives $14.4m for legal costs from Cosette
other announcement
MYX Jefferies Global Healthcare Conference Presentation
other announcement
New DistributeRx partnership with Resilia Pharmaceuticals
other announcement
Mayne Pharma to present at Jefferies Healthcare Conference
other announcement
Mayne Pharma wins $13.27m costs award against Cosette from collapsed $672m takeover battle
Adelaide-based pharmaceutical manufacturer Mayne Pharma (ASX: MYX) has been awarded $13.27 million in legal costs by the Supreme Court of NSW against Cosette Pharmaceuticals, the latest salvo in a protracted dispute stemming from a $672 million takeover deal that collapsed after the Australian Treasurer blocked it on national interest groun...
Court awards MYX $13.27m for legal costs from Cosette
other announcement
Mayne Pharma announces expansion of Adelaide Apothecary
other announcement
Further details re equity instruments to be issued to CEO
other announcement
MYX expects no material impact from US s232 tariffs
other announcement
Mayne Pharma to present at ASX SMIDcaps Conference
other announcement
MYX to claim against Cosette, Avista & Mr David Burgstahler
other announcement
2025 Notice of Annual General Meeting and shareholder pack
other announcement
MYX officially opens newly expanded manufacturing facility
other announcement
Mayne Pharma terminates Scheme Implementation Deed
other announcement
MYX receives purported termination notice from Cosette
other announcement
Mayne Pharma issues notice of intention to terminate the SID
other announcement